Compare Bio Protocol (BIO) vs Golem (GLM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Golem — how do they compare? Bio Protocol trades at Rp516.51 (market cap Rp1,15T, Rp264,79M 24h volume), while Golem trades at Rp1,812 (market cap Rp1,8T, Rp51,65M 24h volume). The key difference: Golem is the larger of the two by market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 1B / 1B GLM (100%) for Golem. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Golem for 19 Days on average.
| BIO | GLM | |
|---|---|---|
Market Cap | Rp1,15T | Rp1,8T |
Volume (24h) | Rp264,79M | Rp51,65M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 1B / 1B GLM (100%) |
Typical Hold Time | 16 Days | 19 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Golem (GLM) is currently trading at Rp1,810 with a market cap of Rp1.8T, showing bearish technical signals as indicated by moving averages. The token is trading near its pivot point of Rp1,807, with immediate support at Rp1,779 and resistance at Rp1,822. With 100% of the 1M token supply in circulation and an average hold time of 19 days, the asset shows full distribution but relatively short-term holding patterns.
Overall outlook remains cautious due to bearish technical indicators, though neutral oscillators suggest potential consolidation. Key opportunities include protocol utility in decentralized computing, while risks involve typical crypto volatility and limited recent ecosystem developments. Investors should monitor support levels closely for potential entry points.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Golem
Golem Network is an open-source, decentralized platform that provides computing power for the AI industry. It operates as a peer-to-peer marketplace where users exchange GLM tokens to rent or share idle computing resources.
Read more on GLM →
